MALVERN, PA — Annovis Bio, Inc. (NYSE: ANVS) announced it has received an “Acceptance Letter” from the New York Stock Exchange (NYSE), confirming the NYSE’s approval of the Company’s plan to regain compliance with listing standards related to minimum market capitalization and stockholders’ equity.
The NYSE has granted the Company an 18-month period, starting from the Notice of Noncompliance dated March 26, 2025 (the “Plan Period”), to meet the required standards. As part of the Plan, the Company must provide quarterly updates on its progress.
The Company expects its stock to remain listed on the NYSE during the Plan Period, provided it adheres to the Plan and complies with other listing standards. This notification does not impact the Company’s business, operations, or SEC reporting requirements.
For the latest news on everything happening in Chester County and the surrounding area, be sure to follow MyChesCo on Google News and MSN.